On December 28, Guangming Science City played host to the commencement of the 5th Brain Science Frontier and Industry Conference, along with the 2025 Shenzhen Brain-Computer Interface Expo. That same day, the 'AI Innovation Alliance for Brain Science and Central Nervous System Diseases in the Guangdong-Hong Kong-Macao Greater Bay Area' was formally inaugurated. This alliance, a collaborative effort involving nearly 20 entities, such as Luye Life Sciences Group, is dedicated to advancing drug innovation for nervous system disorders, brain-computer interfaces, and related fields. Additionally, a brain science industry fund, boasting a total scale of 1.16 billion yuan, was established, accompanied by the signing of its inaugural batch of proposed investment projects. On the 29th, the brain-computer interface concept continued to exhibit robust performance, with Xiangyu Medical and Medlander seeing their shares soar nearly 10%, Sanbo Brain Hospital and Innovation Medical climbing more than 7%, and Aipon Medical and Chengyitong not far behind.